Alzheimer’s, ageing and amyloid: An absurd allegory?

Gerontology

Volumn 43, Issue 1-2, 1997, Pages 132-142

  Fowler, Christopher J ^a   Cowburn, Richard F ^b   Joseph, James A ^c  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c TUFTS UNIVERSITY   (United States)

Author keywords

Alzheimer s disease; Oxidative stress; Signal transduction; amyloid

Indexed keywords

AMYLOID BETA PROTEIN;

AGING; ALZHEIMER DISEASE; ARTICLE; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; HUMANS; SIGNAL TRANSDUCTION;

EID: 0031029245     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000213841     Document Type: Article

References (97)

1. Tomlinson BE, Corsellis JAN: Ageing and the dementias; in Adams JH, Corsellis JAN, Duchen LW (eds): Greenfields Neuropathology, ed 4. New York. Wiley, 1984, pp 951-1025.
2. Terry RD, Katzman R: Senile dementia of the Alzheimer type. Ann Neurol 1983;14:497-506.
3. Winblad B, Wallace W, Hardy J, Fowler CJ, Bucht G, Alafuzoff I, Adolfsson R: Neurochemical, genetic and clinical aspects of Alzheimer’s disease; in Bergener M, Ermini M, Stähelin HB (eds): Dimensions in Aging. London, Academic Press. 1986, pp 183-205.
4. Fowler CJ, Cowburn RF, Garlind A, Winblad B, O’Neill C: Disturbances in signal transduction mechanisms in Alzheimer’s disease. Mol Cell Biochem 1995; 149/150:287-292.
5. Alzheimer A: Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatr 1907;64:146-148.
6. Goate A, Chartier-Harlin M-C, Mullen M, Brown J, Crawford F, Giuffra L, Haynes A, Irving N, Mant JL, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J: Segregation of missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 1991; 349:704-706.
7. Hardy JA, Higgins GA: Alzheimer's disease: The amyloid cascade hypothesis. Science 1992:256:184-185.
8. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE: p-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992; 12: 376-389.
9. Gray CW, Patel AJ: Neurodegeneration mediated by glutamate and β-amyloid peptide: A comparison and possible interaction. Brain Res 1995;691:169-179.
10. Higgins LS, Rodems JM, Catalano R, Quon D, Cordell B: Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for P-APP751. Proc Natl Acad Sci USA 1995:92:4402-4406.
11. Moran PM, Higgins LS, Cordell B, Moser PC: Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human p-amyloid precursor protein. Proc Natl Acad Sci USA 1995;92: 5341-5345.
12. LaFcrla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G: The Alzheimer’s Ap peptide induces ncurodegcneration and apoptotic cell death in transgenic mice. Nature Genet 1995;9:21-30.
13. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Black-well C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hago-pian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J: Alzheimer-type neuropathology in transgenic mice overexpressing V717F p-amyloid precursor protein. Nature 1995;373:523-527.
14. Sherrington R, Rogaev EL Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsu-da T, Mar L, Fonin J-F, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pi-nessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Perciak-Vance M, Tanzi RE, Roses AD, Fraser PE, Rom-mens JM, St George-Hyslop PH: Cloning of a gene bearing missense mutations in carly-onset familial Alzheimer’s disease. Nature 1995; 375:754-760.
15. Clark RF, Hutton M, Fuldner RA, Froehlich S, Karran E, Talbot C, Crook R, Lendon C, Prihar G, He C, Korcnblat K, Martinez A, Wragg M, Busfield F, Behrens MI, Myers A, Norton J, Morris J, Mehta N, Pearson C, Lincoln S, Baker M, Dul TK, Zehr C, Pcrez-Tur J, Houlden H, Ruiz A, Ossa J, Lopera F, Arcos M, Madrigal L, Collingc J, Humphreys C, Ashworth A, Sanier S, Fox N, Harvey R, Kennedy A, Roques P, Cline RT, Philips C, Venter JC, For-sell L, Axclman K, Lilius L, Johnston J, Cowburn R, Viitanen M, Winblad B, Kosik K, Haltia M, Poy-honen M, Dickson D, Mann D, Nea-ry D, Snowden J, Lannfclt L, Rossor M, Roberts GW, Adams MD, Hardy J, Goate A: The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nature Genet 1995:11:219-222.
16. Lcvy-Lahad E, Wijsman EM, Nem-ens E, Anderson L, Goddard KAB, Weber JL, Bird TD, Schellenberg GD: A familial Alzheimer's disease locus on chromosome I, Science 1995:269:970-973.
17. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pcttingcll WH, Yu C-E, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu Y-H, Guenette SY, Galas D, Ncmens E, Wijsman EM, Bird TD, Schellcn-berg GD, Tanzi RE: Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995:269:973-977.
18. Iverscn LL, Mortishire-Smith RJ, Pollack SJ, Shearman MS: The toxicity in vitro of ß-amyloid protein. BiochemJ 1995:311:1-16.
19. Schenk DB, Rydel RE, May P, Little S, Panetta J, Licberburg I, Sinha S: Therapeutic approaches related to amyloid-ß peptide and Alzheimer's disease. J Med Chem 1995:38: 4141-4154.
20. Lahiri DK, Lewis S, Farlow MR: Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines. J Neurosci Res 1994:37: 777-787.
21. Cowbum RF, O’Neill C, Ravid R, Alafuzoff I, Winblad B, Fowler CJ: Adcnylyl cyclase activity in postmortem human brain: Evidence of altered G protein mediation in Alzheimer's disease. J Neurochcm 1992:58:1409-1419.
22. Cowbum RF, Veslling M, Fowler CJ, Ravid R, Winblad B, O'Neill C: Disrupted Pi-adrcnoccptor-G protein coupling in the temporal cortex of patients with Alzheimer’s disease. Neurosci Lett 1993:155:163-166.
23. O’Neill C, Wiehagcr B, Fowler CJ, Ravid R, Winblad B, Cowbum RF: Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain. Brain Res 1994;636:193-201.
24. 2 hydrolysis in Alzheimer’s disease. Life Sci 1993:53: PL439-PL444.
25. Crews FT, Kurian P, Freund G: Cholinergic and serotonincrgic stimulation of phosphoinosi:ide hydrolysis is decreased in Alzheimer’s disease. Life Sci 1994:55:1993-2002.
26. Cutler R, Joseph JA, Yamagami K, Villalobos-Molina R, Roth GS: Area specific alterations in muscarinic stimulated low Km GTPasc activity in aging and Alzheimer’s disease: Implications for altered signal transduction. Brain Res 1994:664:54-60.
27. Cole G, Dobkins KR, Hansen LA, Terry RD, Saitoh T: Decreased levels of protein kinase C in Alzheimer brain. Brain Res 1988:452:165-174.
28. Masliah E, Cole GM, Shimohama S, Hansen LA, DeTeresa R, Terry RD, Saitoh T: Differential involvement of protein kinase C isoenzymes in Alzheimer's disease. J Neurosci 1990:10:2113-2124.
29. 3H]inositol 1,4,5-trisphosphate binding in Alzheimer’s disease. Neurosci Lett 1988:94:198-202.
30. 4 binding in Alzheimer’s disease brain. Brain Res 1995:681:160-166.
31. 3H]MK-801 binding in Alzheimer’s disease. J Neurochem 1989:53:698-704.
32. Saitoh T, Cole G, Huynh TV: Aberrant protein kinase C cascades in Alzheimer’s disease: in Lauder JM (ed): Molecular Aspects of Development and Aging of the Nervous System. New York. Plenum Press. 1990, pp 301-310.
33. Gandy SE, Buxbaum JD, Greengard P: Signal transduction and the pathobiology of Alzheimer’s disease; in Iqbal K, McLachlan DRC, Winblad B, Wisniewski HM (eds): Alzheimer’s Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies. New York. Wiley, 1991. pp 155-172.
34. Nitsch RM, Growdon JH: Role of neurotransmission in the regulation of amyloid ß-protein precursor processing. Biochem Pharmacol 1994; 47:1275-1284.
35. Blass JP, Gibson GE, Black RS, Ko L-W, Shcu K-FR: Cultured skin fibroblasts, ‘Alzheimer antigens’, and cellular calcium homeostasis in Alzheimer’s disease: in FowlerCJ, Carlson LA, Gottfries C-G, Winblad B (eds): Biological Markers in Dementia of Alzheimer Type. London, Smith-Gordon, 1990, pp 203-214.
36. Huang H-M, Gibson GE: Altered ß-adrenergic receptor-stimulated cAMP formation in cultured skin fibroblasts from Alzheimer donors. J Biol Chem 1993:268:14616-14621.
37. Tatcbayashi Y, Takeda M, Kashi-wagi Y, Okochi M, Kurumandani T, Sekiyama A, Kanayanta A, Harigu-chi S, Nishimura T: Ccll-cyclc-dc-pendent abnormal calcium response in fibroblasts from patients with familial Alzheimer’s disease. Dementia 1995:6:9-16.
38. Kunishata T, Ikeda S, Araki W, Ta-bika T: The decrement of muscarinic receptor-mediated calcium influx by overexpression of APP in a mouse cholinergic cell line. Tohoku J Exp Med 1994:174:225-239.
39. Arispe N, Rojas H, Pollard HB: Alzheimer's disease amyloid ß-protein forms calcium channels in bilayer membranes: Blockade by thro-methamine and aluminium. Proc Natl Acad Sei USA 1993:90:567-571.
40. 2+ influx in PC12h cells in culture. Neurosci Lett 1994:173:147-150.
41. Eckert A, Hartmann H, Förstl H, Müller WE: Alterations of intracellular calcium regulation during aging and Alzheimer’s disease in nonneuronal cells. Life Sci 1994:55: 2019-2029.
42. Wu J, Anwyl R, Rowan MJ: ß-Amy-loid-(1-40) increases long-term potentiation in rat hippocampus in vitro. Eur J Pharmacol 1995;284:R1-R3.
43. Chauhan A, Chauhan VPS, Brock-erhoff H, Wisniewski HM: Action of amyloid beta-protein on protein kinase C activity. Life Sei 1991:49: 1555-1562.
44. Wallace MA: Effects of Alzheimer's disease-related ß amyloid protein fragments on enzymes metabolising phosphoinositides in brain. Biochim Biophys Acta 1994; 1227:183-187.
45. Cowburn RF, Wiehager B, Sundström E: ß-Amyloid peptides enhance binding of the calcium mobilising second messengers, inositol(1,4,5)trisphosphatc and inositol-(1,3,4,5)tetrakisphosphate to their receptor sites in rat cortical membranes. Neurosci Lett 1995; 191:31-34.
46. Hartmann H, Eckert A, Förstl H, Müller WE: Similar age-related changes of free intracellular calcium in lymphocytes and central neurons: Effects of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 1994;243:218-223.
47. Fulop T, Kckcssy D, Foris G: Altered post-receptorial signal transduction mechanism under various stimulation in polymorphonuclear granulocytes of Alzheimer’s disease. Mech Age Dev 1990:52:277-285.
48. Yamagami K, Joseph JA, Roth GS: Decrement of muscarinic receptor-stimulated Iow-Km GTPase in striatum and hippocampus from the aged rat. Brain Res 1992:576:327-331.
49. m GTPase in rat striata is diminished with age. Brain Res 1992;590:303-304.
50. Nomura Y, Kitamura Y, Kawai M, Segawa T: co-Adrenoceptor-GTP binding regulatory protein: Adenylate cyclase system in cerebral cortical membranes of adult and senescent rats. Brain Res 1986:379:1 18-124.
51. Rahman S, McLean JH, Darbv-King A, Paterno G, Reynolds JN, Neuman RS: Loss of cortical sero-toninia signal transduction in senescent rats: Reversal following inhibition of protein kinase C. Neuroscience 1995:66:891-901.
52. Joseph JA, Kowatch MA, Maki T, Roth GS: Selective cross-activation/ inhibition of second-messenger systems and the reduction of age-related deficits in the muscarinic control of dopamine release from perifused rat striata. Brain Res 1990:537:40-48.
53. Hartmann H, Eckert A, Miillcr WE: Aging enhances the calcium sensitivity of central neurons of the mouse as an adaptive response to reduced free intracellular calcium. Neurosci Lett 1993:152:181-184.
54. Miyamoto A, Roth GS: Changes in transmembrane signaling mechanisms during aging: Cellular and molecular aspects; in Macieira-Coel-ho A (ed): Molecular Basis of AginG, Boca Raton. CRC Press. 1955, pp 293-306.
55. Chen M, Inestrosa NC, Ross GS, Fernandez Hl.: Platelets are the primary source of amyloid beta-pep-tide in human blood. Biochem Biophys Res Commun 1995:213:96-103.
56. Buxbaum JD, Koo EH, Grecngard P: Protein phosphorylation inhibits production of Alzheimer amyloid ß/ A4 peptide. Proc Natl Acad Sei USA 1993:90:9195-9198.
57. Hung AY, Haass C, Nitsch RM, Qiu WQ, Citron M, Wurtman RJ, Growdon JH, Sclkoe DJ: Activation of protein kinase C inhibits cellular production of the amyloid ß-protein. J Biol Chcm 1993:268:22959-22962.
58. Buxbaum JD, Ruefli AA, Parker CA, Cypess AM, Greengard P: Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-indepcndcnt manner. Proc Natl Acad Sci USA 1994:91:4489-4493.
59. Querforth HW, Selkoe DJ: Calcium ionophore increases amyloid β peptide production by cultured cells. Biochemistry 1994:33:4550-4561.
60. Kinouchi T, Sorimachi H, Maruya-ma K, Mizuno K, Ohno S, lshiura S, Suzuki K: Conventional protein kinase C (PKC)-a and novel PKCE, but not -Ô, increase the secretion of an N-terminal fragment of Alzheimer’s disease amyloid precursor protein from PKC cDNA transfected 3YI fibroblasts. FEBS Lett 1995:364:203-206.
61. Checler F: Processing of the β-amy-loid precursor protein and its regulation in Alzheimer’s disease. J Neu-rochem 1995:65:1431-1444.
62. Eikelenboom P, Zhan S-S, van Gool WA, Allsop D: Inflammatory mechanisms in Alzheimer's disease. Trends Neurosci 1994:15:447-450.
63. Goodwin JL, Uemura E, Cunnick JE: Microglial release of nitric oxide by the synergistic action of p-amy-loidand IFN-Y. Brain Res 1995:692: 207-214.
64. Meda L, Cassatella MA, Szendrei GI, Otvos L, Baron P, Villalba M, Ferrari D, Rossi F: Activation of microglial cells by p-amyloid protein and intcrfcron-Y. Nature 1995:374: 647-650.
65. Leveuglc B, Ding W, Buée L, Fillit HM: Interleukin-1 and nerve growth factor induce hypersecretion and hy-pcrsulfation of neuroblastoma proteoglycans which bind P-amyloid. J Neuroimmunol 1995:60:151-160.
66. Mantione JR, KJeppner SR, Miya-zono M, Wertkin AM, Lee VM-Y, Trojanowski JQ: Human neurons that constitutivcly secrete AP do not induce Alzheimer’s disease pathology following transplantation and long-term survival in the rodent brain. Brain Res 1995:671:333-337.
67. Breitner JCS, Gau BA, Welsh KAS, Plassman BL, McDonald WM, Helms MJ, Anthony JC: Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin control study. Neurology 1994;44:227-232.
68. Rogers J, Kirby LC, Hempetman SR, Berry DL, McGeer PL, Kasz-niak AW, Zalinski J, Coficld M, Mansukhani L, Willson P, Kogan F: Clinical trial of indomethacin in Alzheimer's disease. Neurology 1993;43:1609-1611.
69. Amaducci L, Falcini M, Lippi A: Descriptive epidemiology and risk factors for Alzheimer’s disease. Acta Neurol Scand 1992;(suppl 139):21 -25.
70. Corder EH, Saunders AM, Stritt-matter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vancc MA: Gene dose of apolipoprotcin E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 1993; 261:921-923.
71. Joseph JA: The putative role of free radicals in the loss of neuronal functioning in senescence. Integ Physiol Behav Sci 1992;27:217-227.
72. Harman D: Free radical theory of aginG, Mutation Res 1992:275:257-266.
73. Yu BP: Cellular defenses against damage from reactive oxygen species. Physiol Rev 1994;76:139-162.
74. Olanow CW: An introduction to the free radical hypothesis in Parkinson's disease. Ann Neurol 1992:32: S2-S9.
75. Choi M, Jackson C, Yu BP: Lipid peroxidation contributes to age-related membrane rigidity. Free Rad Biol Med 1995;18:977-984.
76. Choi M, Yu BP: Brain synaptosomal aging: Free radicals and membrane fluidity. Free Rad Biol Med 1995; 18:133-139.
77. Langaniere S, Yu BP: Effect of chronic food restriction in aging ratS, I, Liver subcellular membranes. Mech Age Dev 1989:48: 207-219.
78. Geremia ED, Baratta S, Zafarana R, Giordano MR, Pinizzutto MG, La Rosa M, Garozzo A: Antioxidant enzymatic systems in neuronal and glial cell-enriched fractions of rat brain during aging. Neurochem Res 1990;15:719-723.
79. Gupta A, Hasan M, Chander R, Kapoor NK: Age-related elevation of lipid peroxidation products: Diminution of superoxide dismutase activity in the central nervous system of rats. Gerontology 1991:37:305-309.
80. Devasagayam TPA: Decreased per-oxidative potential in rat brain microsomal fractions during ageing. Neurosci Lett 1989;103:92-96.
81. Benzi G, Pastoris O, Marzatico F, Villa F: Cerebral enzyme antioxidant system influence of aging and phosphatidylcholine. J Cereb Blood Flow Metab 1989;9:373-380.
82. Nistico G, Ciriolo MR, Fiskin K, lannone M, De Artino A, Rotilio G: NGF restores decrease in catalasc activity and increases superoxide dismutase and glutathione peroxide activity in the brain of aged rats. Free Rad Biol Med 1992; 12:177-181.
83. Benkovic SA, Connor JR: Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain. J Comp Neurol 1993;338:97-113.
84. Fowler CJ, Wiberg A, Oreland L, Marcusson J, Winblad B: The effect of age on the activity and molecular properties of human brain monoamine oxidase. J Neural Transm 1980;49:1-20.
85. Carney JM, Starke-Reed PE, Oliver CN, Landum RW, Cheng MS, Wu JF, Floyd RA: Reversal of age-related increase in brain protein oxidation: Decrease in enzyme activity, and loss in temporal and spatial memory by chronic n-terl-butyl-al-pha-phenylnitrone. Proc Natl Acad Sci USA 1991:88:3633-3636.
86. Zhang JRP, Andrus PK, Hall ED: Age-related regional changes in hydroxyl radical stress and antioxidants in gerbil brain. J Neurochem 1993:61:1640-1647.
87. Yu BP: Cellular defenses against damage from reactive oxygen species. Physiol Rev 1994;76:139-162.
88. Migheli A, Cavalla P, Piva R, Gior-dana MT, Schifier D: Bcl-2 protein expression in aged brain and neu-rodegencrative diseases. Neuroreport 1994;5:1906-1908.
89. Benzi G, Moretti A: Are reactive oxygen species involved in Alzheimer’s disease? Neurobiol Aging 1995:16:661-674.
90. Joseph JA, Dalton TK, Hunt WA: Age-related decrements in the muscarinic enhancement of K’-evoked release of endogenous striatal dopamine: An indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence. Brain Res 1988;454:140-148.
91. Joseph JA, Dalton TK, Roth GS, Hunt WA: Alterations in muscarinic control of striatal dopamine autoreceptors in senescence: A deficit at the ligand-muscarinic receptor interface? Brain Res 1988:454:149-155.
92. Joseph JA, Cao G, Cutler RC: In vivo or in vitro administration of the nitronc spin-trapping compound, n-tcrt-butyl-alpha-phenylni-tronc (PBN), reduces age-related deficits in striatal muscarinic receptor sensitivity. Brain Res 1995;671: 73-77.
93. S6Fe heavy-particlc irradiation: Implications for manned space flights. Ra-diat Res 1992:130:88-93.
94. 56Fe heavy-particle irradiation: Further ‘age-ra-diation' parallels. Radiat Res 1993; 135:257-261.
95. 56Fe heavy-particle irradiation-induced deficits in striatal muscarinic receptor sensitivity by selective cross-acti-vation/inhibition of second-messenger systems. Radiat Res 1994:139: 60-66.
96. Villalobos-Molina R, Joseph JA, Rabin BM, Kandasamy SB, Dalton TK, Roth GS: Iron-56 irradiation diminishes muscarinic but not alpha-1 -adrcnergic-stimulatcd low-Km GTPase in rat brain. Radiat Res 1994;140:382-386.
97. Joseph JA, Villalobos-Molina K, Denisova N, Erat S, Cutler R, Strain JG: Age differences in sensitivity to H1O2- or NO-induced reductions in K’-cvokcd dopamine release from superfused striatal slices: Reversals by PBN or Trolox. Free Rad Biol Med 1996:20:821-830.